Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Non-renounceable pro rata Entitlement Offer

Non-renounceable pro rata Entitlement Offer June 14, 2016 • Category • Author Name

Non-renounceable pro rata Entitlement Offer

Latest News

BioDiem receives Innovation Connections grant for Opal work

May 1, 2018

BioDiem receives Innovation Connections grant for Opal work

Read More
Opal BioSciences – Half-year Results & Financial Report

April 9, 2018

Opal BioSciences – Half-year Results Opal Biosciences Limited – Half-year Financial Report 31 Dec 2017

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions